Aldeyra Therapeutics (ALDX) EPS (Basic) (2013 - 2026)
Aldeyra Therapeutics (ALDX) posted EPS (Basic) of -$0.06 for Q1 2026, up 48.11% on a QoQ basis from -$0.11 in Q4 2025, and up 80.52% year-over-year from -$0.03 in Q1 2025.
Aldeyra Therapeutics (ALDX) EPS (Basic) (2013 - 2026) Analysis & Trends
Aldeyra Therapeutics' EPS (Basic) history runs 14 years deep, the most recent figure standing at -$0.06 for Q1 2026.
- Quarterly EPS (Basic) rose 80.52% year-over-year to -$0.06 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.57 (up 52.46% YoY) and the FY2025 annual result came in at -$0.64, up 35.08% from the prior year.
- EPS (Basic) was -$0.06 for Q1 2026 at Aldeyra Therapeutics, up from -$0.11 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.06 in Q1 2026 and bottomed at -$0.71 in Q1 2023.
- A 5-year average of -$0.27 and a median of -$0.26 in 2024 frame the typical range for EPS (Basic).
- Peak annual rise in EPS (Basic) reached 80.73% in 2024, while the deepest fall reached 209.42% in 2024.
- Aldeyra Therapeutics' EPS (Basic) stood at -$0.23 in 2022, then surged by 61.97% to -$0.09 in 2023, then plunged by 209.42% to -$0.26 in 2024, then jumped by 58.37% to -$0.11 in 2025, then soared by 48.11% to -$0.06 in 2026.
- Business Quant data shows ALDX's EPS (Basic) at -$0.06 in Q1 2026, -$0.11 in Q4 2025, and -$0.23 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 0.00 |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -2.29 |
| 10 | Aldeyra Therapeutics | 95.00 Mn | 95.00 Mn | - | -0.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.06 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | -0.23 |
| Jun 30, 2025 | -0.17 |
| Mar 31, 2025 | -0.29 |
| Dec 31, 2024 | -0.26 |
| Sep 30, 2024 | -0.37 |
| Jun 30, 2024 | -0.28 |
| Mar 31, 2024 | -0.14 |
| Dec 31, 2023 | -0.09 |
| Sep 30, 2023 | -0.26 |
| Jun 30, 2023 | -0.44 |
| Mar 31, 2023 | -0.71 |
| Dec 31, 2022 | -0.23 |
| Sep 30, 2022 | -0.33 |
| Jun 30, 2022 | -0.33 |
| Mar 31, 2022 | -0.32 |
| Dec 31, 2021 | -0.30 |
| Sep 30, 2021 | -0.47 |
| Jun 30, 2021 | -0.66 |